Albania vs Chile: Access to anti-retroviral drugs, female
Albania
64.0%
in 2024
Chile
63.0%
in 2024
Albania rank
95th
Chile rank
96th
Access to anti-retroviral drugs, female over time
- Albania
- Chile
How they compare
Albania currently reports 64.0% against 63.0% in Chile, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Chile ahead.
Albania ranks 95th and Chile ranks 96th of 141 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Albania | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.6% | 29.7% | 22.1% | Chile |
| 2010s | 41.2% | 56.4% | 15.2% | Chile |
| 2020s | 61.4% | 65.6% | 4.2% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Albania or Chile?
- Albania, at 64.0% against 63.0% in Chile as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Albania and Chile?
- 1.0%, with Albania ahead.
- How many years of comparable data are there for Albania and Chile?
- 25 years are reported by both, from 2000 to 2024.
- How do Albania and Chile rank globally for access to anti-retroviral drugs, female?
- Albania ranks 95th and Chile ranks 96th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.